Table 1.
Baseline patient demographics with clinical and functional characteristics.
| Baseline Patient Demographics | |
|---|---|
| Male, number (%) | 1 (20) |
| Age, years (mean ± SD) | 58 ± 5 |
| Height, cm (mean ± SD) | 169 ± 15 |
| Weight, kg (mean ± SD) | 82 ± 16 |
| Disease duration, months (mean ± SD) | 314 ± 195 |
| Anti-CCP positivity, number (%) | 3 (60) |
| IgM RF positivity, number (%) | 3 (60) |
| DAS 44 (mean ± SD) | 2.78 ± 0.43 |
| 44-swollen joint count (median ± IQR) | 7 ± 5 |
| 44-tender joint count (median ± IQR) | 6 ± 7 |
| CRP, mg/mL (median ± IQR) | 3 ± 9 |
| ESR, mm/h (median ± IQR) | 9 ± 27 |
| VAS disease activity, 0 – 100 mm (mean ± SD) | 45 ± 19 |
| DMARD therapy, number (%) | 3 (60) |
| Oral prednisolone, number (%) | 4 (80) |
| NSAID therapy, number (%) | 2 (40) |
Abbreviations: IgM RF: immunoglobulin M rheumatoid factor, DAS: disease activity scale, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate, VAS: visual analogue scale, DMARD: disease modifying anti-rheumatic drug, NSAID: non-steroidal anti-inflammatory drug.